Literature DB >> 2157179

Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells.

E Reihsaus1, M Kohler, S Kraiss, M Oren, M Montenarh.   

Abstract

In order to contribute to the understanding of the activation of the oncoprotein p53 we determined the metabolic stability of p53 in a variety of non-transformed, immortalized and SV40- and non-SV40-transformed cell lines. In addition, we analyzed the metabolic stability of the SV40 large T antigen in SV40 transformed cell lines. Pulse-chase experiments revealed a low stability (t1/2 = 20 min) of p53 in non-transformed cells and in cells immortalized by the p53 construct pLTRp53cG9. In cells transformed by an activated ras oncogene and pLTRp53cG9 and in methylcholanthrene induced mouse sarcoma cells p53 proved to be progressively more stable with half-lives ranging from 5.5 h to 7 h. Sequential immunoprecipitation with p53- or T antigen specific monoclonal antibodies allowed us to separate T-p53 complexes, uncomplexed p53 and free T antigen in cell extracts from cells transformed by SV40 and pLTRp53cG9. In these transformed cells uncomplexed p53 showed an increased stability (t1/2 = 2.8 h) when compared to p53 from non-transformed cells. Complex formation with T antigen resulted in an additional stabilization of p53 (t1/2 = 13.3 h). Furthermore, T-p53 complex formation also seems to increase the stability of T antigen nearly sixfold. In transformed cells two immunological variants of p53, a PAb246 precipitable and a non-precipitable form showed distinctly different stabilities, indicating a correlation between the ability of p53 subclasses to bind hsc70 protein and their metabolic stability. Moreover, binding to hsc70 correlated with the stabilization of T antigen in CTM cells also where the mutant T antigen is localized exclusively in the cytoplasm. In abortively infected cells p53, even in complex with T antigen, exhibited a relatively low stability (t1/2 = 87 min) indicating that complex formation per se is not sufficient for fully stabilizing p53.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157179

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.

Authors:  E Shaulian; A Zauberman; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

3.  p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts.

Authors:  G R Ogden; D M Chisholm; R A Kiddie; D P Lane
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

4.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding.

Authors:  D Michael-Michalovitz; F Yehiely; E Gottlieb; M Oren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Differentiation and growth potential of human ovarian surface epithelial cells expressing temperature-sensitive SV40 T antigen.

Authors:  E H Leung; P C Leung; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

7.  JNK targets p53 ubiquitination and degradation in nonstressed cells.

Authors:  S Y Fuchs; V Adler; T Buschmann; Z Yin; X Wu; S N Jones; Z Ronai
Journal:  Genes Dev       Date:  1998-09-01       Impact factor: 11.361

8.  The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.

Authors:  C Cayrol; E K Flemington
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

9.  Primary squamous cell carcinoma of the endometrium unrelated to human papilloma virus: a molecular study.

Authors:  Giovanna Giordano; Silvia Pizzi; Cinzia Azzoni; Lorena Bottarelli; Tiziana D'Adda
Journal:  Pathol Oncol Res       Date:  2013-02-21       Impact factor: 3.201

10.  Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.

Authors:  Gad Asher; Joseph Lotem; Leo Sachs; Chaim Kahana; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.